From: Chronic granulomatous disease: a review of the infectious and inflammatory complications
Prophylaxis of Infection | Â |
Antibacterial therapy | Trimethoprim-sulfamethoxazole (TMP-SMX) 5 mg/kg/day (based upon the TMP component, maximum dose 320 mg P.O in two divided daily doses) [187] |
Antifungal therapy | Itraconazole 5 mg/kg [85] (maximum dose 200 mg orally daily) |
Immunomodulatory therapy | Interferon-gamma (IFN-γ) [85, 137] 50 μg/m2 (subcutaneous) three times a week 1.5 μg/Kg (subcutaneous) three times a week for children <0.5 m2 |
Management of Infection | Â |
Empirical treatment | TMP-SMX/Fluoroquinolone/Antifungal (Voriconazole) |
 |    • Burkholderia, Serratia species: TMP-SMX |
 |    • Nocardia species: TMP-SMX and/or Cabapenem |
 |    • Staphylococcus aureus:TMP-SMX or Vancomycin |
 |    • Fungal infection: Antifungal agent ±Steroid |
Liver abscess | |
Granulocyte Transfusion | |
Definitive treatment | Â |
Stem cell transplant | HLA identical sibling umbilical cord stem cell transplantation (UCSCT) after myeloablative conditioning (Stem cell transplantation from a HLA-identical donor may, at present, be the only proven curative approach to CGD) [185–187] |
Gene therapy |